GW's Epidiolex development is initially concentrating on severe, orphan, early - onset, treatment -
resistant epilepsy syndromes including Dravet syndrome, Lennox - Gastaut syndrome (LGS), Tuberous Sclerosis Complex (TSC) and Infantile Spasms (IS).
Not exact matches
Using a novel combination of technologies, including trio exome sequencing of patient / parental DNA and genetic studies in the tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset of
epilepsy patients with symptoms similar to Dravet
syndrome — a severe form of childhood
epilepsy that is in many patients
resistant to currently available anti-epileptic drugs.
Around the globe there is high interest in the use of cannabidiol (CBD), a type of cannabinoid, for the treatment of people with
epilepsy, especially children who have treatment -
resistant forms of the disorder such as Lennox - Gastaut
Syndrome (LGS) and Dravet
Syndrome (DS).
Dravet
syndrome is a severe form of pediatric
epilepsy characterized by frequent daily drug -
resistant seizures and developmental delays.
Other research has found this condition in individuals with cerebellar ataxia, stiff man
syndrome, type I diabetes, drug -
resistant epilepsy, balance problems and more (16).